J0670 HCPCS Level II code: Injection, mepivacaine hydrochloride, per 10 ml
J0670 is the HCPCS code for “Injection, mepivacaine hydrochloride, per 10 ml” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0670Injection, mepivacaine hydrochloride, per 10 ml
Short description: Inj mepivacaine hcl/10 ml
HCPCS · United States
Medicare details
The indicators CMS publishes with J0670 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1986
Where J0670 sits
- 1J codesDrugs administered other than orally
- 2Active code J0670Injection, mepivacaine hydrochloride, per 10 ml
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0670 mean?
J0670 is the HCPCS code for “Injection, mepivacaine hydrochloride, per 10 ml” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0670?
CMS lists J0670’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0670
All J codesJ0651Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcgJ0652Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcgJ0654Injection, liothyronine, 1 mcgJ0665Injection, bupivicaine, not otherwise specified, 0.5 mgJ0666Injection, bupivacaine liposome, 1 mgJ0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mgJ0675Injection, carboprost tromethamine, 0.1 mgJ0681Injection, ceftobiprole medocaril sodium, 3 mgJ0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mgJ0688Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mgJ0689Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mgJ0690Injection, cefazolin sodium, 500 mg